×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NLSP – nls pharmaceutics ltd. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NLSP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
07:45 am
nlsp
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders [Yahoo! Finance]
11/18
07:30 am
nlsp
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
Medium
Report
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
11/4
07:00 am
nlsp
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
Medium
Report
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
10/28
07:00 am
nlsp
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
Low
Report
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
10/21
07:00 am
nlsp
NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
High
Report
NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
10/15
07:00 am
nlsp
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
High
Report
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
9/25
08:00 am
nlsp
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Low
Report
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:13 pm
nlsp
Form F-3/A NLS Pharmaceutics Ltd.
Low
Report
Form F-3/A NLS Pharmaceutics Ltd.
11/18
08:30 am
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Nov 18
Medium
Report
Form 6-K NLS Pharmaceutics Ltd. For: Nov 18
11/15
05:00 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Nov 15
Medium
Report
Form 6-K NLS Pharmaceutics Ltd. For: Nov 15
11/14
07:27 pm
nlsp
Form SC 13G/A NLS Pharmaceutics Ltd. Filed by: Lind Global Fund II LP
Medium
Report
Form SC 13G/A NLS Pharmaceutics Ltd. Filed by: Lind Global Fund II LP
11/14
03:34 pm
nlsp
Form SC 13G NLS Pharmaceutics Ltd. Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SC 13G NLS Pharmaceutics Ltd. Filed by: ARMISTICE CAPITAL, LLC
11/12
04:01 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Nov 12
High
Report
Form 6-K NLS Pharmaceutics Ltd. For: Nov 12
11/8
04:00 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Nov 08
Low
Report
Form 6-K NLS Pharmaceutics Ltd. For: Nov 08
11/6
04:00 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Nov 06
Low
Report
Form 6-K NLS Pharmaceutics Ltd. For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: